Increased Cancer-Related Mortality for Patients With Type 2 Diabetes Who Use Sulfonylureas or Insulin
Response to Bowker et al.
- Azeez Farooki, MD and
- Stephen H. Schneider, MD
- From the Memorial Sloan Kettering Cancer Center, New York, New York; and the University of Medicine and Dentistry of New Jersey-Robert Wood Johnson Medical School, New Brunswick, New Jersey
- Address correspondence to Azeez Farooki, MD, Memorial Sloan Kettering Cancer Center, 1275 York Ave., Box 296, New York, NY 10021. E-mail: farookia{at}mskcc.org
Article Information
vol. 29 no. 8 1989-1990
PubMed
Published By
Print ISSN
Online ISSN
History
- Published in print July 27, 2006.
Copyright & Usage
DIABETES CARE
Author Information
- Azeez Farooki, MD and
- Stephen H. Schneider, MD
- From the Memorial Sloan Kettering Cancer Center, New York, New York; and the University of Medicine and Dentistry of New Jersey-Robert Wood Johnson Medical School, New Brunswick, New Jersey
- Address correspondence to Azeez Farooki, MD, Memorial Sloan Kettering Cancer Center, 1275 York Ave., Box 296, New York, NY 10021. E-mail: farookia{at}mskcc.org
Statistics from Altmetric.com
Article usage
In this Issue
August 2006, 29(8)
Increased Cancer-Related Mortality for Patients With Type 2 Diabetes Who Use Sulfonylureas or Insulin
